Reliance Industries Leads Market Gains as Brokerages Raise Targets Post Strong Q1

Reliance Industries Leads Market Gains as Brokerages Raise Targets Post Strong Q1

Reliance Industries Gains Broker Confidence with Digital Growth Focus

Reliance Industries (RIL) shares gained attention after multiple brokerages maintained bullish ratings post strong Q1 results. Goldman Sachs maintains Buy with a ₹1,870 target, CLSA retains Outperform at ₹1,800, and Morgan Stanley stays Overweight at ₹1,750. The O2C segment outperformed with 17% QoQ EBITDA growth, while retail margins faced pressure from digital investments. Brokerages highlight RIL's potential to double retail EBITDA in 3 years through FMCG, media, and new energy initiatives.

  • Positive impact: RIL's weight in Nifty (10.8%) could drive index performance. Brokerage upgrades may attract institutional flows.
  • What to watch: Execution of 120 GWh battery capacity plans and JioMart's dark store expansion.

VA Tech Wabag Secures ₹600 Cr Bengaluru Water Project

VA Tech Wabag surged 5% after winning a ₹600 crore order from BWSSB for wastewater treatment facilities in Bengaluru, including 100 MLD STP and 25 MLD TTP with 7-year O&M. This follows earlier ₹1,100 crore Middle East orders, with management guiding 15-20% revenue growth despite West Asia delays.

  • Positive impact: Order book visibility supports mid-cap stock's 60% YTD rally. Sector peers like Ion Exchange may see spillover interest.
  • What to watch: Bidding pipeline for Namami Gange Phase-II projects.

Shyam Metalics Approves ₹4,500 Cr Fundraise Amid Strong Q1

Shyam Metalics approved raising ₹4,500 crore via QIP/NCDs after reporting 23% revenue growth (₹5,455 Cr) and 18% PAT rise (₹345 Cr) in Q1. EBITDA grew 32% to ₹765 Cr with firm realizations. The board also declared ₹1.8/share interim dividend.

  • Positive impact: Steel sector sentiment improves with Jefferies/JPMorgan maintaining Buy ratings on JSW Steel.
  • What to watch: Dolvi Phase 3 commissioning by September 2027.

Banking Sector Shows Divergence

HDFC Bank dropped 4.5% after Investec downgraded to Hold (₹920 target) citing NIM at post-merger low (3.26%). Conversely, Indian Overseas Bank surged 3.5% as Q1 PAT rose 49% YoY to ₹1,659 Cr with GNPA improving to 1.33%. Federal Bank posted strong CASA growth (35-36% target).

  • Negative impact: HDFC Bank's weight (13.3% in Nifty Bank) pressured the index.
  • What to watch: CEO succession at HDFC Bank and FCNR mobilization progress.

Tata Technologies Faces Brokerage Skepticism

Tata Technologies fell 3% despite Q1 revenue beat as Kotak (Sell, ₹500) and JPMorgan (Underweight, ₹540) flagged rich valuations at 32x FY28 P/E. Management reiterated double-digit FY27 growth but Germany headwinds persist.

  • Negative impact: May cool overheated mid-cap IT valuations.
  • What to watch: Auto OEM spending recovery in Europe.

Adani Green Energy Gets Macquarie Upgrade

Macquarie raised Adani Green target to ₹1,800 (30% upside) citing 30% EBITDA CAGR over 5 years from 5.5GW annual capacity additions. FY28-29 EBITDA estimates lifted 6-10% despite near-term interest cost pressures.

  • Positive impact: Could revive renewable energy sector interest.
  • What to watch: BESS integration progress at Khavda Solar Park.

Goldman Sachs Initiates Coverage on Industrial Stocks

GS initiated Buy on Craftsman Automation (₹11,600 target) citing data-center power demand and Sansera Engineering (₹4,130 target) for aerospace/semiconductor exposure. Bharat Forge rated Neutral (₹2,120) on valuation concerns.

  • Positive impact: Sansera surged 6% post initiation.
  • What to watch: PLI benefits in precision engineering.

Suven Life Sciences Advances CNS Drug Trials

Suven Life rose 117% in 6 months as phase 3 trials progress for CNS drug Masupirdine (FY27-28 launch target). The company raised ₹858 crore and established a Singapore subsidiary for global expansion despite FY26 ₹2,763 Cr R&D-driven loss.

  • Mixed impact: High-risk biotech play with binary outcomes.
  • What to watch: Phase 3 trial data readouts.

Chembond Materials Posts 43.5% Profit Growth

Chembond Materials reported 43.5% YoY net profit growth to ₹5.73 crore in Q1 FY27 with revenue up 25.6% to ₹72.42 crore. EPS improved to ₹4.26 from ₹2.97, reflecting specialty chemicals demand.

  • Positive impact: Validates niche chemical players' growth potential.
  • What to watch: Capacity utilization at new Gujarat plant.

Market Outlook

Reliance Industries' strength and renewable energy momentum may support Nifty, while banking sector divergence could keep indices range-bound. Mid-caps like VA Tech Wabag and Sansera Engineering show order-driven upside, but rich valuations in IT/auto ancillaries warrant caution. Investors await UltraTech Cement's capacity expansion details and global commodity trends.

Share this article:
Back to Blog